The anti-insulin trimolecular complex in type 1 diabetes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 4, 2010, Pages 329-334

  Michels, Aaron W ^a   Nakayama, Maki ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

autoimmunity; diabetes; human leukocyte antigen; insulin; T cell receptor

Indexed keywords

AUTOANTIGEN; INSULIN ANTIBODY; T LYMPHOCYTE RECEPTOR; AUTOANTIBODY; INSULIN; LYMPHOCYTE ANTIGEN RECEPTOR; MACROMOLECULE;

AMINO ACID SEQUENCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MUTATION; NONHUMAN; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; BIOLOGICAL MODEL; BLOOD; IMMUNOLOGY; MACROMOLECULE; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; MACROMOLECULAR SUBSTANCES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MODELS, BIOLOGICAL; RECEPTORS, ANTIGEN, T-CELL;

EID: 77955773620     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32833aba41     Document Type: Review

References (63)

1. Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008; 371:1777-1782.
2. Lie BA, Ronningen KS, Akselsen HE, et al. Application and interpretation of transmission/disequilibrium tests: transmission of HLA-DQ haplotypes to unaffected siblings in 526 families with type 1 diabetes. Am J Hum Genet 2000; 66:740-743.
3. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide/ HLA-DQ8 complex and susceptibility to type 1 diabetes. Nature Immunol 2001; 2:501-507.
4. Corper AL, Stratmann T, Apostolopoulos V, et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000; 288:505-511.
5. Suri A, Vidavsky I, van der DK, et al. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J Immunol 2002; 168:1235-1243.
6. Suri A, Walters JJ, Gross ML, Unanue ER. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J Clin Invest 2005; 115:2268-2276.
7. Suri A, Walters JJ, Rohrs HW, et al. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules. J Immunol 2008; 180:3849-3856.
8. Erlich H, Valdes AM, Noble J, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57:1084-1092.
9. Reichstetter S, Kwok WW, Nepom GT. Impaired binding of a DQ2 and DQ8- binding HSV VP16 peptide to a DQA1-0501/DQB1-0302 trans class II heterodimer. Tissue Antigens 1999; 53:101-105.
10. Tollefsen S, Arentz-Hansen H, Fleckenstein B, et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006; 116:2226-2236.
11. Nakanishi K, Inoko H. Combination of HLA-A24, -DQA1-03, and -DR9 contributes to acute-onset and early complete beta-cell destruction in type 1 diabetes: longitudinal study of residual beta-cell function. Diabetes 2006; 55:1862-1868.
12. Nejentsev S, Howson JM, Walker NM, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450:887-892.
13. Aly TA, Baschal EE, Jahromi MM, et al. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 2008; 57:770-776.
14. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39:857-864.
15. Pugliese A, Zeller M, Fernandez A, et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet 1997; 15:293-297.
16. Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002; 51:1383-1390.
17. Palmer JP, Asplin CM, Clemons P, et al. Insulin antibodies in insulindependent diabetics before insulin treatment. Science 1983; 222:1337-1339.
18. Achenbach P, Koczwara K, Knopff A, et al. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114:589-597.
19. Alleva DG, Crowe PD, Jin L, et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001; 107:173-180.
20. Kent SC, Chen Y, Bregoli L, et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005; 435:224-228.
21. Mannering SI, Harrison LC, Williamson NA, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005; 202:1191-1197.
22. Mannering SI, Pang SH, Williamson NA, et al. The A-chain of insulin is a hotspot for CD4 T cell epitopes in human type 1 diabetes. Clin Exp Immunol 2009; 156:226-231.
23. Pinkse GG, Tysma OH, Bergen CA, et al. Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 2005; 102:18425-18430.
24. Hassainya Y, Garcia-Pons F, Kratzer R, et al. Identification of naturally processed HLA-A2 - Restricted proinsulin epitopes by reverse immunology. Diabetes 2005; 54:2053-2059.
25. Toma A, Haddouk S, Briand JP, et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A 2005; 102:10581-10586.
26. Skowera A, Ellis RJ, Varela-Calvino R, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008; 118:3390-3402.
27. Jarchum I, DiLorenzo TP. Ins2 deficiency augments spontaneous HLAA-0201-restricted T cell responses to insulin. J Immunol 2010; 184:658-665.
28. Wegmann DR, Norbury-Glaser M, Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in prediabetic NOD mice. Eur J Immunol 1994; 24:1853-1857.
29. Halbout P, Briand JP, Becourt C, et al. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J Immunol 2002; 169:2436-2443.
30. Levisetti MG, Suri A, Petzold SJ, Unanue ER. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J Immunol 2007; 178:6051-6057.
31. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995; 25:1056-1062.
32. Jasinski JM, Yu L, Nakayama M, et al. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 2006; 55:1978-1984.
33. Mohan JF, Levisetti MG, Calderon B, et al. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010; 11:350-354.
34. Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 1996; 93:956-960.
35. Alleva DG, Gaur A, Jin L, et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 2002; 51:2126-2134.
36. Kobayashi M, Abiru N, Arakawa T, et al. Altered B:9 23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes. J Immunol 2007; 179:2082-2088.
37. French MB, Allison J, Cram DS, et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1996; 46:34-39.
38. Jaeckel E, Lipes MA, von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 2004; 5:1028-1035.
39. Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J Exp Med 2003; 197:1635-1644.
40. Krishnamurthy B, Dudek NL, McKenzie MD, et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006; 116:3258-3265.
41. Fan Y, Rudert WA, Grupillo M, et al. Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J 2009; 28:2812-2824.
42. Nakayama M, Abiru N, Moriyama H, et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005; 435:220-223.
43. Nakayama M, Babaya N, Miao D, et al. Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout. J Autoimmun 2005; 25:193-198.
44. Nakayama M, Beilke JN, Jasinski JM, et al. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 2007; 117:1835-1843.
45. Chen W, Bergerot I, Elliott JF, et al. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 2001; 167:4926-4935.
46. Bresson D, Togher L, Rodrigo E, et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Investig 2006; 116:1371-1381.
47. Levisetti MG, Lewis DM, Suri A, Unanue ER. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes 2008; 57:1852-1860.
48. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298:1395-1401.
49. Gardner JM, DeVoss JJ, Friedman RS, et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008; 321:843-847.
50. Yip L, Su L, Sheng D, et al. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 2009; 10:1026-1033.
51. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol 2005; 87:123-162; 123-162
52. Stadinski BD, Delong T, Reisdorph N, et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010; 11:225-231.
53. Dogra RS, Vaidyanathan P, Prabakar KR, et al. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetol 2006; 49:953-957.
54. Simone E, Daniel D, Schloot N, et al. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci USA 1997; 94:2518-2521.
55. Kobayashi M, Jasinski J, Liu E, et al. Conserved T cell receptor alpha-chain induces insulin autoantibodies. Proc Natl Acad Sci U S A 2008; 105:10090-10094.
56. Reijonen H, Mallone R, Heninger AK, et al. GAD65-specific CD4 T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 2004; 53:1987-1994.
57. Gebe JA, Yue BB, Unrath KA, et al. Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms. J Immunol 2009; 183:59-65.
58. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 2005; 6:490-496.
59. Li Y, Huang Y, Lue J, et al. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J 2005; 24:2968-2979.
60. Maynard J, Petersson K, Wilson DH, et al. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 2005; 22:81-92.
61. Feng D, Bond CJ, Ely LK, et al. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction codon. Nat Immunol 2007; 8:975-983.
62. Lennon GP, Bettini M, Burton AR, et al. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009; 31:643-653.
63. Li L, He Q, Garland A, et al. Tisch R. beta cell-specific CD4 T cell clonotypes in peripheral blood and the pancreatic islets are distinct. J Immunol 2009; 183:7585-7591.